Urpo Lamminmäki
PhD
urplammi@utu.fi +358 29 450 4587 +358 50 476 5557 Kiinamyllynkatu 10 Turku |
Antibody engineering, Bioaffinity assays, in vitro diagnostics
My research is largely focused to recombinant antibodies and other bioaffinity molecules. I am interested in developing techniques used for tailoring such molecules as well as applications of these molecules in various fields including diagnostics, drug development and biomarker discovery.
Methods and application of molecular biotechnology
Antibody and protein engineering techniques
Protein chemistry
Diagnostics
6 of 10
- (2018)
- Clinical Cancer ResearchAnalytical and Bioanalytical Chemistry
- Array-in-well epitope mapping of phage-displayed antibodies (2018) Epitope Mapping Protocols Urpo Lamminmäki, Gaurav Batra, Petri Saviranta
- CA125 glycoform assay improves the performance of conventional CA125 in the diagnostics of epithelial ovarian cancer (2018)
- International Journal of Gynecological Cancer
- Molecular tools for selective recovery and detection of lignin-derived molecules (2018)
- Green Chemistry
- Array-in-well binding assay for multiparameter screening of phage displayed antibodies (2017)
- Methods
- Effect of DNA sequence of Fab fragment on yield characteristics and cell growth of E-coli (2017)
- Scientific Reports
- Non-competitive ELISA with broad specificity for microcystins and nodularins (2017)
- Advances in Oceanography and Limnology
- Rapid and Highly Sensitive Non-Competitive Immunoassay for Specific Detection of Nodularin (2017)
- Microorganisms
- Super-sensitive time-resolved fluoroimmunoassay for thyroid-stimulating hormone utilizing europium(III) nanoparticle labels achieved by protein corona stabilization, short binding time, and serum preprocessing. (2017)
- A Nanoparticle-Lectin Immunoassay Improves Discrimination of Serum CA125 from Malignant and Benign Sources (2016)
- Clinical Chemistry
UTU Research Portal